Whole Genome And Exome Sequencing Market Size Projected To Reach $6.14 Billion By 2034 With A Cagr Of 24.9%

The Whole Genome And Exome Sequencing Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Projected Growth of the Whole Genome And Exome Sequencing Market?
In recent times, the market size for whole genome and exome sequencing has observed a significant expansion. The market, which is currently worth $2.02 billion as of 2024, is predicted to increase to $2.53 billion in 2025, representing a compound annual growth rate (CAGR) of 24.8%. Factors such as lower sequencing costs, an increase in genetic disorders, clinical applications, genomic data repositories, and advancements in bioinformatics are credited for the growth witnessed in the previous period.

The market size for whole genome and exome sequencing is anticipated to experience substantial expansion in the coming years, culminating in a valuation of $6.14 billion by 2029, which corresponds to a compound annual growth rate (CAGR) of 24.9%. This projected surge over the forecasting duration is linked to various factors such as the initiatives taken towards population genomics, an increasing prerequisite for precision medicine, gains in single-cell sequencing, broadening of non-invasive prenatal testing (NIPT), and its application in researching rare diseases. Key trends predicted for the forecasted period are the widespread adoption in clinical domains, swift progress in sequencing technologies, the emergence of large-scale genomic studies, the incorporation of artificial intelligence (AI) and machine learning (ML), and the proliferation of applications in the field of oncology.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13957

What Are the Different Whole Genome And Exome Sequencing Market Segments?
The whole genome and exome sequencing market covered in this report is segmented -

1) By Product Type: Kits, Instruments
2) By Workflow: Whole Genome Sequencing (WGS), Whole Exome Sequencing (WES)
3) By Applications: Diagnostics, Cancer, Monogenic Disorders, Diabetes, Drug Discovery And Development, Personalized Medicine, Agriculture And Animal Research, Other Applications
4) By End user: Research Center, Academic And Government Institutions, Hospitals And Clinics, Pharmaceutical And Biotechnology Companies, Other End Users

Subsegments:
1) By Kits: Library Preparation Kits, Target Enrichment Kits, DNA Extraction Kits
2) By Instruments: Next-Generation Sequencing (NGS) Systems, Sanger Sequencing Systems, Third-Generation Sequencing Systems

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13957&type=smp

What Are the Primary Drivers Shaping the Whole Genome And Exome Sequencing Market?
The increasing interest in personalized healthcare is anticipated to boost the expansion of the whole genome and exome sequencing market going forward. This medical strategy focuses on personalizing healthcare choices and interventions based on individual traits of each patient, taking into account aspects like genetics, environment, and lifestyle. Whole genome and exome sequencing plays a key role in personalized healthcare as it offers a complete insight into a person's genetic profile, enabling healthcare solutions and interventions tailored to their specific genetic, environmental, and lifestyle circumstances. For example, the Personalized Medicine Coalition (PMC), an American organization endorsing the knowledge and use of personalized medicine, forecasted in October 2022 that more than 75,000 genetic testing products and 300 personalized medicines will be available in the market in 2022. Adding to this, the Center for Drug Evaluation and Research (CDER) of the Food and Drug Administration sanctioned 37 new molecular entities (NMEs) in 2022. Furthermore, approximately 34% (or 12) of the 35 therapeutic NMEs are categorized as personalized. Hence, the increasing interest in personalized healthcare is fueling the expansion of the whole genome and exome sequencing market.

Which Companies Are Leading in the Whole Genome And Exome Sequencing Market?
Major companies operating in the whole genome and exome sequencing market report are Siemens AG, Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Cytiva (Danaher Corporation), Laboratory Corporation of America Holdings (Labcorp), Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Canon Medical Systems Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V, Neusoft Corporation, BGI Genomics, Mirion Technologies (Capintec) Inc., Novogene Co., Oxford Nanopore Technologies Inc., LANDAUER, Pacific Biosciences of California Inc., Digirad Corporation, Berthold Technologies GmbH & Co.KG, GENEWIZ Inc., Incom Inc., Lucerno Dynamics LLC, Absolute Imaging Inc., Mediso Ltd., Ashby Gorman Baker Ltd., DDD-Diagnostic AS, SurgicEye GmbH, CMR Naviscan

What Are the Major Trends Shaping the Whole Genome And Exome Sequencing Market?
Leading corporations in the whole genome and exome sequencing markets are prioritizing the advancement of cutting-edge technological solutions like ultra-fast NGS (next-generation sequencing) analysis to outshine their competitors. Ultra-fast NGS analysis is a progressive innovation designed to process the next-generation sequencing (NGS) data at an incredibly high pace, thereby drastically cutting down the time needed for analyzing genomic data. For example, in January 2023, QIAGEN Digital Insights (QDI), a biotechnology company from the US, rolled out the ultra-fast NGS analysis platform. Its notable features include processing a full genome in 25 minutes at $1 in cloud computing expenses, thus improving efficiency, affordability, and scalability. This transformative technological development remarkably speeds up genomic data analysis and access, contributing significantly to the whole genome and exome sequencing market by facilitating faster decision-making and broader acceptance of personalized medicine.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/whole-genome-and-exome-sequencing-global-market-report

What Are the Top Revenue-Generating Geographies in the Whole Genome And Exome Sequencing Market?
North America was the largest region in the whole genome and exome sequencing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the whole genome and exome sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Whole Genome And Exome Sequencing Market?
2. What is the CAGR expected in the Whole Genome And Exome Sequencing Market?
3. What Are the Key Innovations Transforming the Whole Genome And Exome Sequencing Industry?
4. Which Region Is Leading the Whole Genome And Exome Sequencing Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.